| 1 |
34896572 | Repositioning application of polyoxyethylene (20) sorbitan monooleate on ocular drug resistance and cancer multi-drug resistance by inhibiting the ATPase activity of human multidrug resistance protein 1 and P-glycoprotein. | 2022 Jan |
2 |
| 2 |
34927791 | Unexpected gene activation following CRISPR-Cas9-mediated genome editing. | 2022 Feb 3 |
1 |
| 3 |
35173861 | Apatinib inhibits paclitaxel resistance of gastric carcinoma cells through VEGFR2 pathway. | 2022 |
1 |
| 4 |
35186774 | Corrigendum: Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein. | 2022 |
1 |
| 5 |
35205672 | DKK3, Downregulated in Invasive Epithelial Ovarian Cancer, Is Associated with Chemoresistance and Enhanced Paclitaxel Susceptibility via Inhibition of the β-Catenin-P-Glycoprotein Signaling Pathway. | 2022 Feb 12 |
2 |
| 6 |
35240035 | Utilization of Photoaffinity Labeling to Investigate Binding of Microtubule Stabilizing Agents to P-Glycoprotein and β-Tubulin. | 2022 Mar 25 |
2 |
| 7 |
35327403 | Infigratinib (BGJ 398), a Pan-FGFR Inhibitor, Targets P-Glycoprotein and Increases Chemotherapeutic-Induced Mortality of Multidrug-Resistant Tumor Cells. | 2022 Mar 3 |
3 |
| 8 |
35330134 | Interaction Analysis of MRP1 with Anticancer Drugs Used in Ovarian Cancer: In Silico Approach. | 2022 Mar 7 |
2 |
| 9 |
35350768 | The Resistance of Cancer Cells to Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, is Mediated by the ABCB1 Transporter. | 2022 |
3 |
| 10 |
35449387 | Ketone-selenoesters as potential anticancer and multidrug resistance modulation agents in 2D and 3D ovarian and breast cancer in vitro models. | 2022 Apr 21 |
1 |
| 11 |
35533911 | An ester derivative of tenacigenin B from Marsdenia tenacissima (Roxb.) Wight et Arn reversed paclitaxel-induced MDR in vitro and in vivo by inhibiting both P-gp and MRP2. | 2022 Aug 10 |
3 |
| 12 |
35614289 | Bioactivity inspired C19-diterpenoid alkaloids for overcoming multidrug-resistant cancer. | 2022 May 25 |
1 |
| 13 |
33289076 | PAMAM G4.5 dendrimers for targeted delivery of ferulic acid and paclitaxel to overcome P-glycoprotein-mediated multidrug resistance. | 2021 Mar |
7 |
| 14 |
33326171 | GSTP1 and ABCB1 Polymorphisms Predicting Toxicities and Clinical Management on Carboplatin and Paclitaxel-Based Chemotherapy in Ovarian Cancer. | 2021 Mar |
1 |
| 15 |
33360797 | Design, synthesis, and biological evaluation of hederagenin derivatives with improved aqueous solubility and tumor resistance reversal activity. | 2021 Feb 5 |
2 |
| 16 |
33429062 | Formulation effects on paclitaxel transfer and uptake in the human placenta. | 2021 Apr |
1 |
| 17 |
33506275 | Differential expression of ABCB1, ABCG2, and KLF4 as putative indicators for paclitaxel resistance in human epithelial type 2 cells. | 2021 Feb |
3 |
| 18 |
33506900 | Exosomes derived from Taxol-resistant nasopharyngeal carcinoma (NPC) cells transferred DDX53 to NPC cells and promoted cancer resistance to Taxol. | 2021 Jan |
2 |
| 19 |
33545700 | Recent progress in nanoformulations of cabazitaxel. | 2021 Feb 5 |
1 |
| 20 |
33729781 | Discovery of Encequidar, First-in-Class Intestine Specific P-glycoprotein Inhibitor. | 2021 Apr 8 |
1 |
| 21 |
33793827 | Physcion-8-O-β-d-glucoside interferes with the nuclear factor-κB pathway and downregulates P-glycoprotein expression to reduce paclitaxel resistance in ovarian cancer cells. | 2021 Mar 8 |
1 |
| 22 |
33795638 | Utidelone inhibits growth of colorectal cancer cells through ROS/JNK signaling pathway. | 2021 Apr 1 |
1 |
| 23 |
33875073 | Polyethyleneimine- -Tocopherol Hydrogen Succinate/Hyaluronic Acid-Quercetin (PEI-TOS/HA-QU) Core-Shell Micelles Delivering Paclitaxel for Combinatorial Treatment of MDR Breast Cancer. | 2021 Mar 1 |
1 |
| 24 |
33960504 | Oral paclitaxel with encequidar compared to intravenous paclitaxel in patients with advanced cancer: A randomised crossover pharmacokinetic study. | 2021 Dec |
2 |
| 25 |
34011375 | Graphene oxide (GO)-based nanosheets with combined chemo/photothermal/photodynamic therapy to overcome gastric cancer (GC) paclitaxel resistance by reducing mitochondria-derived adenosine-triphosphate (ATP). | 2021 May 19 |
4 |
| 26 |
34022909 | pH-activated, mitochondria-targeted, and redox-responsive delivery of paclitaxel nanomicelles to overcome drug resistance and suppress metastasis in lung cancer. | 2021 May 22 |
1 |
| 27 |
34031188 | TP53 Null Mutations Identify Lung Cancer Cell Lines with Highest Sensitivity to the Nontaxane Microtubule Inhibitor Eribulin. | 2021 Aug |
1 |
| 28 |
34268580 | Differences in P-glycoprotein activity in human and rodent blood-brain barrier assessed by mechanistic modelling. | 2021 Sep |
2 |
| 29 |
34270886 | Histone demethylase KDM5A enhances cell proliferation, induces EMT in lung adenocarcinoma cells, and have a strong causal association with paclitaxel resistance. | 2021 Jul 16 |
2 |
| 30 |
34276826 | Exploring the potential of functional polymer-lipid hybrid nanoparticles for enhanced oral delivery of paclitaxel. | 2021 May |
2 |
| 31 |
34280009 | ABCB1 Single Nucleotide Polymorphism Genotypes as Predictors of Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer. | 2021 Jul |
4 |
| 32 |
34313784 | Drug resistance via radixin-mediated increase of P-glycoprotein membrane expression during SNAI1-induced epithelial-mesenchymal transition in HepG2 cells. | 2021 Dec 7 |
2 |
| 33 |
34347777 | Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer. | 2021 |
7 |
| 34 |
34360846 | Effects of Dihydrotanshinone I on Proliferation and Invasiveness of Paclitaxel-Resistant Anaplastic Thyroid Cancer Cells. | 2021 Jul 28 |
1 |
| 35 |
34617400 | Targeted paclitaxel-octreotide conjugates inhibited the growth of paclitaxel-resistant human non-small cell lung cancer A549 cells in vitro. | 2021 Nov |
1 |
| 36 |
34648615 | Host cells with transient overexpression of MDR1 as a novel in vitro model for evaluating on-target effect for activity against the epicellular Cryptosporidium parasite. | 2021 Dec 24 |
1 |
| 37 |
34723530 | Discovery of the Triazolo[1,5-a]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance. | 2021 Nov 11 |
4 |
| 38 |
34745981 | Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein. | 2021 |
1 |
| 39 |
34835622 | A Multifunctional Polymeric Micelle for Targeted Delivery of Paclitaxel by the Inhibition of the P-Glycoprotein Transporters. | 2021 Oct 26 |
3 |
| 40 |
34858183 | Tissue Type Differences in ABCB1 Expression and Paclitaxel Tissue Pharmacokinetics in Patients With Esophageal Cancer. | 2021 |
1 |
| 41 |
34977876 | Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cells. | 2021 Dec |
2 |
| 42 |
31628941 | Inhibition of aldehyde dehydrogenase-1 and p-glycoprotein-mediated multidrug resistance by curcumin and vitamin D3 increases sensitivity to paclitaxel in breast cancer. | 2020 Jan 5 |
3 |
| 43 |
31846802 | Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors. | 2020 Feb |
4 |
| 44 |
31937590 | Peripheral neuropathy from paclitaxel: risk prediction by serum microRNAs. | 2020 Jan 14 |
1 |
| 45 |
31967866 | Reversal of P-glycoprotein-mediated multidrug resistance by novel curcumin analogues in paclitaxel-resistant human breast cancer cells. | 2020 Aug |
1 |
| 46 |
31993509 | Microtubule-targeting anticancer drug eribulin induces drug efflux transporter P-glycoprotein. | 2020 Mar |
5 |
| 47 |
32092870 | Overexpression of ABCB1 Transporter Confers Resistance to mTOR Inhibitor WYE-354 in Cancer Cells. | 2020 Feb 19 |
1 |
| 48 |
32108588 | Identification of a lathyrane-type diterpenoid EM-E-11-4 as a novel paclitaxel resistance reversing agent with multiple mechanisms of action. | 2020 Feb 28 |
3 |
| 49 |
32156786 | Decitabine Response in Breast Cancer Requires Efficient Drug Processing and Is Not Limited by Multidrug Resistance. | 2020 May |
1 |
| 50 |
32176509 | Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance. | 2020 Apr 6 |
1 |